Willingness of college students to receive COVID-19 heterologous vaccination: Comment. [PDF]
Kleebayoon A, Wiwanitkit V.
europepmc +1 more source
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV. [PDF]
Kim JY +30 more
europepmc +1 more source
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly. [PDF]
Ferreira IATM +32 more
europepmc +1 more source
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study. [PDF]
Butta NV +17 more
europepmc +1 more source
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile. [PDF]
Díaz-Dinamarca DA +25 more
europepmc +1 more source
Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey. [PDF]
Yıldırım S +35 more
europepmc +1 more source
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination. [PDF]
Lo Tartaro D +19 more
europepmc +1 more source
Acute perimyocarditis following heterologous vaccination of CoronaVac and BNT162b2 SARS-CoV-2 vaccine in an elderly woman. [PDF]
Ching S, Yue CS.
europepmc +1 more source
Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273. [PDF]
Hernández J +8 more
europepmc +1 more source
Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac Plus BNT162b2: A Prospective Cohort Study [PDF]
Demirhindi H +7 more
europepmc +2 more sources

